GGrantIndex
← Leaderboards

Charles George Eberhart

Johns Hopkins University

$6,496,191
Attributed
$7,890,660
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $604.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,890,660 · 6

By mechanism

R01$3,210,877 · 1
T32$2,575,244 · 1
K08$862,110 · 1
R21$837,429 · 2
R56$405,000 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorPathway InteractionsSignal TransductionMalignant Neoplasm Of BrainStemLigandsBrain NeoplasmsNotch ProteinIn VitroNeoplastic CellCellsMedulloblastomaStem CellsPropertyPathologyNerve Stem CellGliomaMolecularGrowthInhibitor/AntagonistChildAnticancer ResearchOncogenesAutomobile Driving

Grant awards (30)

Opportunities for Pathology Trainees in Cancer Research$374,609
T32 · FY2025 · CA
Opportunities for Pathology Trainees in Cancer Research$367,850
T32 · FY2024 · CA
Opportunities for Pathology Trainees in Cancer Research$111,986
T32 · FY2023 · CA
Opportunities for Pathology Trainees in Cancer Research$287,894
T32 · FY2022 · CA
Opportunities for Pathology Trainees in Cancer Research$308,267
T32 · FY2021 · CA
Opportunities for Pathology Trainees in Cancer Research$225,052
T32 · FY2019 · CA · contact PI
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma$172,735
R21 · FY2019 · CA · contact PI
Opportunities for Pathology Trainees in Cancer Research$274,899
T32 · FY2018 · CA · contact PI
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma$213,694
R21 · FY2018 · CA
Opportunities for Pathology Trainees in Cancer Research$273,646
T32 · FY2017 · CA · contact PI
Opportunities for Pathology Trainees in Cancer Research$3,761
T32 · FY2017 · CA · contact PI
Effectively Targeting Notch in Hypoxic Brain Tumor Cells$353,983
R01 · FY2016 · NS · contact PI
Opportunities for Pathology Trainees in Cancer Research$215,631
T32 · FY2016 · CA · contact PI
Effectively Targeting Notch in Hypoxic Brain Tumor Cells$353,991
R01 · FY2015 · NS · contact PI
Opportunities for Pathology Trainees in Cancer Research$131,649
T32 · FY2015 · CA · contact PI
Effectively Targeting Notch in Hypoxic Brain Tumor Cells$355,639
R01 · FY2014 · NS · contact PI
Effectively Targeting Notch in Hypoxic Brain Tumor Cells$364,276
R01 · FY2013 · NS · contact PI
Effectively Targeting Notch in Hypoxic Brain Tumor Cells$405,000
R56 · FY2012 · NS · contact PI
Notch signaling in brain tumors$351,575
R01 · FY2011 · NS · contact PI
Notch signaling in brain tumors$355,163
R01 · FY2010 · NS · contact PI
Notch signaling in brain tumors$358,750
R01 · FY2009 · NS · contact PI
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)$205,000
R21 · FY2009 · AT · contact PI
Notch signaling in brain tumors$358,750
R01 · FY2008 · NS · contact PI
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)$246,000
R21 · FY2008 · AT · contact PI
Notch signaling in brain tumors$358,750
R01 · FY2007 · NS · contact PI
Myc Signaling in Medulloblastomas$172,422
K08 · FY2006 · NS · contact PI
Myc Signaling in Medulloblastomas$172,422
K08 · FY2005 · NS
Myc Signaling in Medulloblastomas$172,422
K08 · FY2004 · NS
Myc Signaling in Medulloblastomas$172,422
K08 · FY2003 · NS
Myc Signaling in Medulloblastomas$172,422
K08 · FY2002 · NS